Xiaojing Cao - Publications

Upfront Thermal Ablation versus Neoadjuvant Chemotherapy Followed by Ablation for Oligometastatic Colorectal Liver Metastases: A Propensity Score Matching Analysis.

Journal: Cardiovascular and interventional radiology

Published: January 28, 2026

Impact of time to ablation on survival outcomes in patients with colorectal liver metastases: an inverse probability-weighted cohort study.

Journal: BMC cancer

Published: January 26, 2026

Early Recurrence of Colorectal Liver Metastasis (Number ≤ 5 and Largest Diameter ≤ 3 cm) after Resection or Thermal Ablation: a Multi-center Study of Patterns, Safety, Survival and Risk Factors.

Journal: Journal of gastrointestinal cancer

Published: March 02, 2025

Efficacy of first-line radiofrequency ablation combined with systemic chemotherapy plus targeted therapy for initially unresectable colorectal liver metastases.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: February 02, 2025

Prognostic Value of Changes in Combined Child-Pugh Class and ALBI Grade in Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Plus Targeted Therapy and PD-(L)1 Inhibitors.

Journal: Journal of hepatocellular carcinoma

Published: September 16, 2024

The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors.

Journal: Journal of hepatocellular carcinoma

Published: August 27, 2024

The Prognostic Value of CRP/Alb Ratio in Predicting Overall Survival for Hepatocellular Carcinoma Treated with Transcatheter Intra-Arterial Therapy Combined with Molecular-Targeted Agents and PD-1/PD-L1 Inhibitors.

Journal: Journal of inflammation research

Published: June 19, 2024

Color-coded parametric imaging support display of vessel hemorrhage-an in vitro experiment and clinical validation study.

Journal: Frontiers in cardiovascular medicine

Published: February 22, 2024

Gut microbiota as a prognostic biomarker for unresectable hepatocellular carcinoma treated with anti-PD-1 therapy.

Journal: Frontiers in genetics

Published: January 05, 2024

Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization.

Journal: European journal of radiology open

Published: November 16, 2023

Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma.

Journal: Hepatology international

Published: November 14, 2022

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: April 26, 2022